search
Back to results

A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Malawi
Study Type
Interventional
Intervention
OraQuick® HIV Self-Test
Sponsored by
London School of Hygiene and Tropical Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for HIV/AIDS focused on measuring HIV, HIV Self-Testing, Malawi

Eligibility Criteria

15 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged ≥ 15 years
  • Residence in GVH catchment areas included in the intervention arm

Exclusion Criteria:

  • Aged < 15 years old
  • Not resident in GVH catchment areas included in the intervention arm

Sites / Locations

  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

HIVST campaign arm

SOC arm

Arm Description

Community representatives will be supported to plan and administer an HIVST campaign linked to HIV care and prevention services in their communities.

Standard HTS will be provided by MoH at health facilities.

Outcomes

Primary Outcome Measures

Percentage of self-reported lifetime testing in adolescents aged 15-19 years old

Secondary Outcome Measures

Percentage of self-reported testing in last 3 months in men aged ≥ 15 years
Percentage of self-reported testing in last 3 months in adults aged ≥ 40 years
Cumulative incidence of population-level ART uptake in adults aged ≥ 15 years over 6 months
Measure of knowledge of HIV prevention methods
Measure of HIV testing stigma.

Full Information

First Posted
May 17, 2018
Last Updated
August 7, 2020
Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Liverpool School of Tropical Medicine, University College, London, Population Services International, UNITAID
search

1. Study Identification

Unique Protocol Identification Number
NCT03541382
Brief Title
A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])
Official Title
Community-led Distribution of HIV Self-tests: a Cluster Randomised Trial Investigating Uptake of HIV Testing and Linkage to Treatment and Prevention, Costs and Safety in Rural Malawi (HIV Self-Testing Africa [STAR])
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
October 8, 2018 (Actual)
Primary Completion Date
July 31, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London School of Hygiene and Tropical Medicine
Collaborators
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Liverpool School of Tropical Medicine, University College, London, Population Services International, UNITAID

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
The aim of this study is to determine the benefits, costs and safety of community-led delivery of HIV self-testing (HIVST) kits in rural Malawi, with a focus on testing and linkage to care and prevention services among defined population sub-groups: men, adolescents aged 15-19 years old, and adults aged 40 years or older.
Detailed Description
RESEARCH QUESTION Can community-led delivery of HIV self-tests be used to maximise public health and social benefits and reduce costs without introducing social harms? RESEARCH AIMS AND OBJECTIVES The broad aim is to determine the benefits, costs and safety of community-led delivery of HIVST kits in rural Malawi, with a focus on testing and linkage to care and prevention services among defined population sub-groups: men, adolescents aged 15-19 years old, and adults aged 40 years or older. The specific objectives are to conduct a cluster randomised controlled trial to: Establish the effectiveness of community-led HIVST campaigns on lifetime and recent HIV testing in predefined sub-groups. Investigate the impact of community-led HIVST campaigns on: (a) population-level initiation of antiretroviral therapy (ART) and uptake of voluntary medical male circumcision (VMMC), (b) knowledge of HIV prevention, (c) stigma reduction Explore how differences in community-led HIVST campaigns affect uptake of HIVST and linkage to care and prevention and values, attitudes and behaviours around HIVST. Estimate the costs and cost-effectiveness of community-led HIVST campaigns compared to the standard of care (SOC). RESEARCH DESIGN The main study consists of a cluster-randomised trial evaluating the effectiveness of community-led HIVST campaigns on coverage of HIV testing and linkage to follow-on services compared to the Ministry of Health (MoH) SOC, facility-based HIV testing services (HTS). We are also interested in understanding the cost-effectiveness of community-led HIVST campaigns, and broader social benefits on stigma reduction. The unit of randomisation is the Group Village Head (GVH), who are traditionally-appointed leaders that oversee a group of villages, and their catchments areas. Outcomes are measured through (i) household surveys in evaluation villages selected for each study cluster, and (ii) clinic records of patients coming from the study clusters. For the primary outcome, measured using the households surveys, we assume that lifetime testing rates for adolescents aged 15-19 years old in the SOC arm are 35-50%, based on the recent Demographic and Health Survey. With 16 clusters per arm and 50 adolescents per cluster, we will have at least 90% power to detect a 20% absolute increase in lifetime testing using a coefficient of variation of outcomes (k) of 0.25. If k=0.3, for a 20% increase in lifetime testing, we would have 90% and 80% power with SOC testing rates of 35-40% and 45-55%, respectively. If the absolute increase in lifetime testing is lower at 15%, then for k=0.25 we would have 80% power for SOC testing rates of 35-40%. With adolescents making up 20-25% of the adult population, this will require 250 adults per cluster. SUB-STUDIES We will also be conducting a series of sub-studies related to the trial, including: Process evaluation to monitor progress of the intervention and adherence to guidelines, and understand how differences in the context-driven intervention affect HIVST uptake and linkage to care and prevention. Qualitative evaluation to explore which aspects of the community-led intervention were pivotal in affecting HIV testing and linkage outcomes and values, attitudes and behaviours around HIVST. Economic evaluation to estimate costs, cost-effectiveness and cost-benefit per individual tested, newly diagnosed as HIV positive, started on ART and circumcised.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
HIV, HIV Self-Testing, Malawi

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
7880 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HIVST campaign arm
Arm Type
Active Comparator
Arm Description
Community representatives will be supported to plan and administer an HIVST campaign linked to HIV care and prevention services in their communities.
Arm Title
SOC arm
Arm Type
No Intervention
Arm Description
Standard HTS will be provided by MoH at health facilities.
Intervention Type
Device
Intervention Name(s)
OraQuick® HIV Self-Test
Intervention Description
Community leaders, including GVHs, Village Health Committee members, Village Development Committee members, and members of key community groups will participate in a workshop to facilitate planning of a HIVST campaign. Identified community distributors, who are unpaid volunteers from the community, will also receive a training package in HIVST promotion. Campaigns will be conducted over a short period (approximately seven days) and under a fixed budget. Community distributors will deliver HIVST kits free of charge to community members, and provide information on how to self-test and access the nearest clinic for linkage to confirmatory HTS, treatment and prevention. Distributors will also provide HIV prevention messages around serodiscordancy, treatment as prevention and VMMC.
Primary Outcome Measure Information:
Title
Percentage of self-reported lifetime testing in adolescents aged 15-19 years old
Time Frame
Measured 8-12 weeks post-intervention
Secondary Outcome Measure Information:
Title
Percentage of self-reported testing in last 3 months in men aged ≥ 15 years
Time Frame
Measured 8-12 weeks post-intervention
Title
Percentage of self-reported testing in last 3 months in adults aged ≥ 40 years
Time Frame
Measured 8-12 weeks post-intervention
Title
Cumulative incidence of population-level ART uptake in adults aged ≥ 15 years over 6 months
Time Frame
Measured 6-months post-intervention
Title
Measure of knowledge of HIV prevention methods
Time Frame
Measured 8-12 weeks post-intervention
Title
Measure of HIV testing stigma.
Time Frame
Measured 8-12 weeks post-intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged ≥ 15 years Residence in GVH catchment areas included in the intervention arm Exclusion Criteria: Aged < 15 years old Not resident in GVH catchment areas included in the intervention arm
Facility Information:
Facility Name
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
City
Blantyre
Country
Malawi

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
34275869
Citation
Indravudh PP, Fielding K, Sande LA, Maheswaran H, Mphande S, Kumwenda MK, Chilongosi R, Nyirenda R, Johnson CC, Hatzold K, Corbett EL, Terris-Prestholt F. Pragmatic economic evaluation of community-led delivery of HIV self-testing in Malawi. BMJ Glob Health. 2021 Jul;6(Suppl 4):e004593. doi: 10.1136/bmjgh-2020-004593.
Results Reference
derived
PubMed Identifier
33974621
Citation
Indravudh PP, Fielding K, Kumwenda MK, Nzawa R, Chilongosi R, Desmond N, Nyirenda R, Neuman M, Johnson CC, Baggaley R, Hatzold K, Terris-Prestholt F, Corbett EL. Effect of community-led delivery of HIV self-testing on HIV testing and antiretroviral therapy initiation in Malawi: A cluster-randomised trial. PLoS Med. 2021 May 11;18(5):e1003608. doi: 10.1371/journal.pmed.1003608. eCollection 2021 May.
Results Reference
derived
PubMed Identifier
31533646
Citation
Indravudh PP, Fielding K, Kumwenda MK, Nzawa R, Chilongosi R, Desmond N, Nyirenda R, Johnson CC, Baggaley RC, Hatzold K, Terris-Prestholt F, Corbett EL. Community-led delivery of HIV self-testing to improve HIV testing, ART initiation and broader social outcomes in rural Malawi: study protocol for a cluster-randomised trial. BMC Infect Dis. 2019 Sep 18;19(1):814. doi: 10.1186/s12879-019-4430-4.
Results Reference
derived

Learn more about this trial

A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])

We'll reach out to this number within 24 hrs